Samir Rashmikant Patel - Nov 24, 2021 Form 4/A - Amendment Insider Report for CytoDyn Inc. (CYDY)

Role: Director
Signature: /s/ Antonio Migliarese, Attorney-In-Fact
Stock symbol: CYDY
Transactions as of: Nov 24, 2021
Transactions value $: $0
Form type: 4/A - Amendment
Date filed: 11/30/2021, 05:31 PM
Date Of Original Report: Nov 29, 2021
Previous filing: Oct 20, 2021
Next filing: Jan 2, 2024
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Shares	Change %	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CYDY	Non-qualified Stock Option	Disposed to Issuer	-225K	-100%	0	Nov 24, 2021	Common Stock	225K	$1.39	Direct	F1
transaction	CYDY	Non-qualified Stock Option	Award	+113K		113K	Nov 24, 2021	Common Stock	113K	$1.39	Direct	F1
transaction	CYDY	Non-qualified Stock Option	Disposed to Issuer	-225K	-100%	0	Nov 24, 2021	Common Stock	225K	$6.15	Direct	F1, F2
transaction	CYDY	Non-qualified Stock Option	Award	+225K		225K	Nov 24, 2021	Common Stock	225K	$6.15	Direct	F1, F2
transaction	CYDY	Non-qualified Stock Option	Disposed to Issuer	-12.3K	-100%	0	Nov 24, 2021	Common Stock	12.3K	$2.25	Direct	F1
transaction	CYDY	Non-qualified Stock Option	Award	+12.3K		12.3K	Nov 24, 2021	Common Stock	12.3K	$2.25	Direct	F1

Showing 1 to 6 of 6 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Samir Rashmikant Patel is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id	Content
F1	The term of the Reporting Person's Continuous Service (as defined in the Issuer's 2012 Equity Incentive Plan, as amended (the "2012 Plan")) as a director of the Issuer ended as of the conclusion of the Issuer's 2021 Annual Meeting of Stockholders on November 24, 2021. Effective immediately prior to the end of the Reporting Person's Continuous Service, each outstanding stock option that had been granted to the Reporting Person under the 2012 Plan was amended to (a) vest and become immediately exercisable, to the extent it would have become vested on December 1, 2021, with the balance of the unvested portion of such option, if any, immediately forfeited, and (b) cause the option to remain exercisable through the original expiration date instead of terminating 90 days following the end of the Reporting Person's Continuous Service.
F2	56,250 shares vested on August 31, 2020; the balance vested in equal amounts on November 30, 2020, February 28, 2021, and May 31, 2021.

Content

The term of the Reporting Person's Continuous Service (as defined in the Issuer's 2012 Equity Incentive Plan, as amended (the "2012 Plan")) as a director of the Issuer ended as of the conclusion of the Issuer's 2021 Annual Meeting of Stockholders on November 24, 2021. Effective immediately prior to the end of the Reporting Person's Continuous Service, each outstanding stock option that had been granted to the Reporting Person under the 2012 Plan was amended to (a) vest and become immediately exercisable, to the extent it would have become vested on December 1, 2021, with the balance of the unvested portion of such option, if any, immediately forfeited, and (b) cause the option to remain exercisable through the original expiration date instead of terminating 90 days following the end of the Reporting Person's Continuous Service.

56,250 shares vested on August 31, 2020; the balance vested in equal amounts on November 30, 2020, February 28, 2021, and May 31, 2021.